<i>IRF5</i> siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis
Zhongshan He(University of Virginia), Xiangrong Song(Sichuan University), Duotian Qin(Brigham and Women's Hospital), Zhong-Hui Duan(Beijing YouAn Hospital), Yongjiang Li(Brigham and Women's Hospital), Zhuoming Zhou(Brigham and Women's Hospital), Yan Kang(Sichuan University), Chunling Jiang(Sichuan University), Haixing Shi(Sichuan University), Yaoyao Luo(Sichuan University), Ji Zhang(University of California San Diego), Wei Chen(Army Medical University), Wanqin Zeng(Sichuan University), Bin Su(Capital Medical University), Yu Guo(Green Chemistry), Xi He(Hunan Agricultural University)
Cited by 5
Related Papers
mRNA-based therapeutics: powerful and versatile tools to combat diseases
|Signal Transduction and Targeted Therapy|2022|710
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
|Nature Reviews Cardiology|2021|487
Microalgae-based oral microcarriers for gut microbiota homeostasis and intestinal protection in cancer radiotherapy
|Nature Communications|2022|236
Orally deliverable strategy based on microalgal biomass for intestinal disease treatment
|Science Advances|2021|229